Time to initiation of antiretroviral therapy in HIV-infected patients diagnosed with an opportunistic disease: a cohort study

被引:6
|
作者
Deconinck, L. [1 ,2 ,5 ]
Yazdanpanah, Y. [2 ,3 ]
Gilson, R. J. [1 ,4 ]
Melliez, H. [5 ]
Viget, N. [5 ]
Joly, V. [3 ]
Sabin, C. A. [1 ]
机构
[1] UCL, UCL Res Dept Infect & Populat Hlth, London, England
[2] Paris Diderot Univ, Decis Sci Infect Dis Prevent Control & Care, IAME, Sorbonne Paris Cite,UMR 1137, Paris, France
[3] Bichat Claude Bernard Hosp, Dept Infect Dis, Paris, France
[4] Cent & North West London NHS Fdn Trust, Mortimer Market Ctr, London, England
[5] Tourcoing Hosp, Lille Sch Med, Dept Infect Dis, Tourcoing, France
关键词
AIDS-related opportunistic infections; antiretroviral therapy; HIV; time to treatment; CONSEQUENCES; AIDS;
D O I
10.1111/hiv.12201
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
ObjectivesThe aim of the study was to identify factors associated with the time between opportunistic disease (OD) diagnosis and antiretroviral therapy (ART) initiation in HIV-infected patients presenting for care with an OD, and to evaluate the outcomes associated with any delay. MethodsA multicentre cohort study was undertaken in London, Paris and Lille/Tourcoing. The medical records of patients diagnosed from 2002 to 2012 were reviewed. ResultsA total of 437 patients were enrolled in the study: 70% were male, the median age was 40 years, 42% were from sub-Saharan Africa, 68% were heterosexual, the median CD4 count was 40cells/L, and the most common ODs were Pneumocystis pneumonia (37%), tuberculosis (24%), toxoplasmosis (12%) and Kaposi's sarcoma (11%). Of these patients, 400 (92%) started ART within 24 weeks after HIV diagnosis, with a median time from OD diagnosis to ART initiation of 30 [interquartile range (IQR) 16-58] days. Patients diagnosed between 2009 and 2012 had a shorter time to ART initiation than those diagnosed in earlier years [hazard ratio (HR) 2.07; 95% confidence interval (CI) 1.58-2.72]. Factors associated with a longer time to ART initiation were a CD4 count200cells/L (HR 0.30; 95% CI 0.20-0.44), tuberculosis (HR 0.40; 95% CI 0.30-0.55) and diagnosis in London (HR 0.62; 95% CI 0.48-0.80). Patients initiating deferred' ART (by 30 days) exhibited no difference in disease progression or immunovirological response compared with patients who had shorter times to ART initiation. Patients in the deferred' group were less likely to have ART modifications (HR 0.69; 95% CI 0.48-1.00) and had shorter in-patient stays (mean 14.2 days shorter; 95% CI 8.9-19.5 days) than patients in the group whose ART was not deferred. ConclusionsThe time between OD diagnosis and ART initiation remains heterogeneous and relatively long, particularly in individuals with a high CD4 count or tuberculosis or those diagnosed in London. Deferring ART was associated with fewer ART modifications and shorter in-patient stays.
引用
收藏
页码:219 / 229
页数:11
相关论文
共 50 条
  • [1] Initiation of antiretroviral therapy in HIV-infected tuberculosis patients in rural Kenya: an observational study
    Stockdale, Alexander J.
    Nkuranga, Joseph
    Toeroek, M. Estee
    Faragher, Brian
    Lalloo, David G.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2013, 18 (07) : 907 - 914
  • [2] Antiretroviral therapy of HIV-infected patients
    Gölz, J
    MEDIZINISCHE WELT, 1999, 50 (06): : 223 - 229
  • [3] CHARACTERISTICS OF GRAVES DISEASE IN HIV-INFECTED PATIENTS ON ANTIRETROVIRAL THERAPY
    Jariyawattanarat, Vitvala
    Sungkanuparph, Somnuek
    Sriphrapradang, Chutintorn
    ENDOCRINE PRACTICE, 2020, 26 (06) : 612 - 618
  • [4] Differences in prescription of antiretroviral therapy in a large cohort of HIV-Infected patients
    McNaghten, AD
    Hanson, DL
    Dworkin, MS
    Jones, JL
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 32 (05) : 499 - 505
  • [5] Predictors of Opportunistic Infections among HIV-infected Patients on Antiretroviral Therapy: A Cross-Sectional Study
    Gebru, Tsegu Hailu
    Mekonen, Haftea Hagos
    Kiros, Kbrom Gemechu
    Gebremedhin, Haftom Tesfay
    Teklemichael, Beyene Tadesse
    Tesfamichael, Yohannes Ashebir
    CLINICAL NURSING RESEARCH, 2023, 32 (07) : 1057 - 1065
  • [6] Optimum Timing of Antiretroviral Therapy for HIV-Infected Patients with Concurrent Serious Opportunistic Infections
    Meintjes, Graeme
    Wilkinson, Robert J.
    CLINICAL INFECTIOUS DISEASES, 2010, 50 (11) : 1539 - 1541
  • [7] Incidence and Risk Factors for Renal Disease in an Outpatient Cohort of HIV-Infected Patients on Antiretroviral Therapy
    Doshi, Saumil
    Ucanda, Martin
    Hart, Rachel
    Hou, Qingjiang
    Terzian, Arpi S.
    Subramanian, Thilakavathy
    Binkley, Jeffery
    Taylor, Rob
    Rayeed, Nabil
    Akridge, Cheryl
    Purinton, Stacey
    Naughton, Jeff
    D'Angelo, Lawrence
    Kharfen, Michael
    Wood, Angela
    Serlin, Michael
    Kumar, Princy
    Parenti, David
    Castel, Amanda
    Greenberg, Alan
    Monroe, Anne
    Happ, Lindsey Powers
    Jaurretche, Maria
    Lewis, Brittany
    Peterson, James
    Younes, Naji
    Wilcox, Ronald
    Rana, Sohail
    Horberg, Michael
    Fernandez, Ricardo
    Hebou, Annick
    Dieffenbach, Carl
    Masur, Henry
    Bordon, Jose
    Teferi, Gebeyehu
    Benator, Debra
    Ruiz, Maria Elena
    Goldstein, Deborah
    Hardy, David
    KIDNEY INTERNATIONAL REPORTS, 2019, 4 (08): : 1075 - 1084
  • [8] Cytokine patterns in a prospective cohort of HIV-infected patients with cryptococcal meningitis following initiation of antifungal and antiretroviral therapy
    Mora, Delio Jose
    Ferreira-Paim, Kennio
    Andrade-Silva, Leonardo Euripedes
    Bragine, Thatiane
    Rocha, Ivonete Helena
    Ribeiro, Barbara de Melo
    Machado, Guilherme Henrique
    Rodrigues Junior, Virmondes
    Silva-Teixeira, David Nascimento
    Meyer, Wieland
    Silva-Vergara, Mario Leon
    PLOS ONE, 2017, 12 (05):
  • [9] ANTIRETROVIRAL THERAPY IN HIV-INFECTED PATIENTS - UPDATE
    BARTLETT, JG
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1994, 3 (05) : 340 - 344
  • [10] ANTIRETROVIRAL THERAPY IN ADULT HIV-INFECTED PATIENTS
    SALZBERGER, B
    SCHRAPPE, M
    DIEHL, V
    INTERNIST, 1994, 35 (12): : 1095 - 1104